FDA Notifies Ash Access of Approved IDE for MethLock

The FDA has approved a clinical trial for a new and much more effective formulation of MethLock, a catheter lock solution developed by Ash Access Technology, a Lafayette, Ind., company focused on vascular access medical solutions to prevent catheter-related bloodstream infections (CRBSI).

Yahoo News (http://biz.yahoo.com/prnews/050322/detu012_3.html)